280 related articles for article (PubMed ID: 26289583)
21. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
22. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
23. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
24. Blood pressure lowering effects of β-blockers as add-on or combination therapy: A meta-analysis of randomized controlled trials.
Guo QH; Zhu ZM; Feng YQ; Lin JX; Wang JG
J Clin Hypertens (Greenwich); 2023 Mar; 25(3):227-237. PubMed ID: 36756690
[TBL] [Abstract][Full Text] [Related]
25. Systematic review: antihypertensive drug therapy in black patients.
Brewster LM; van Montfrans GA; Kleijnen J
Ann Intern Med; 2004 Oct; 141(8):614-27. PubMed ID: 15492341
[TBL] [Abstract][Full Text] [Related]
26. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.
Pongpanich P; Pitakpaiboonkul P; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
Int Urol Nephrol; 2018 Dec; 50(12):2261-2278. PubMed ID: 30324578
[TBL] [Abstract][Full Text] [Related]
27. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
Musini VM; Nazer M; Bassett K; Wright JM
Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
[TBL] [Abstract][Full Text] [Related]
28. Intraclass differences among antihypertensive drugs.
Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Copland E; Canoy D; Nazarzadeh M; Bidel Z; Ramakrishnan R; Woodward M; Chalmers J; Teo KK; Pepine CJ; Davis BR; Kjeldsen S; Sundström J; Rahimi K;
Lancet Oncol; 2021 Apr; 22(4):558-570. PubMed ID: 33794209
[TBL] [Abstract][Full Text] [Related]
30. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis: impact of drug class on adherence to antihypertensives.
Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
[TBL] [Abstract][Full Text] [Related]
32. First-line drugs for hypertension.
Wright JM; Musini VM; Gill R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD001841. PubMed ID: 29667175
[TBL] [Abstract][Full Text] [Related]
33. Urocortin 2 in patients with hypertension treated with angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Walczewska J; Siga O; Dzieza-Grudnik A; Krolczyk J; Wizner B; Wolkow PP; Borys A; Kolton-Wroz M; Gryglewska B; Grodzicki T
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31443094
[TBL] [Abstract][Full Text] [Related]
34. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
Law MR; Morris JK; Wald NJ
BMJ; 2009 May; 338():b1665. PubMed ID: 19454737
[TBL] [Abstract][Full Text] [Related]
35. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Nazarzadeh M; Bidel Z; Canoy D; Copland E; Wamil M; Majert J; Smith Byrne K; Sundström J; Teo K; Davis BR; Chalmers J; Pepine CJ; Dehghan A; Bennett DA; Smith GD; Rahimi K;
Lancet; 2021 Nov; 398(10313):1803-1810. PubMed ID: 34774144
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
Asayama K; Ohkubo T; Metoki H; Obara T; Inoue R; Kikuya M; Thijs L; Staessen JA; Imai Y;
Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063
[TBL] [Abstract][Full Text] [Related]
37. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Reboussin DM; Allen NB; Griswold ME; Guallar E; Hong Y; Lackland DT; Miller EPR; Polonsky T; Thompson-Paul AM; Vupputuri S
Circulation; 2018 Oct; 138(17):e595-e616. PubMed ID: 30354656
[TBL] [Abstract][Full Text] [Related]
38. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
[TBL] [Abstract][Full Text] [Related]
39. Predictors of high central blood pressure in young with isolated systolic hypertension.
Radchenko GD; Torbas OO; Sirenko YM
Vasc Health Risk Manag; 2016; 12():321-8. PubMed ID: 27536127
[TBL] [Abstract][Full Text] [Related]
40. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Chaugai S; Meng WY; Ali Sepehry A
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
